IP Library Granted Patent US 12,324,930
Granted Patent B2
US 12,324,930 · App. 18/612,071 · Granted Jun 10, 2025

Systems and methods for automatic treatment planning and optimization

Inventors: Jarkko Peltola (Tuusula, FI); Pauli Suhonen (Helsinki, FI); Christopher Boylan (Helsinki, FI); Stephen Thompson (Palo Alto, CA); Esa Kuusela (Helsinki, FI)
Assignee: SIEMENS HEALTHINEERS INTERNATIONAL AG
A61N5/1031A61N5/1075G06F17/10A61N2005/1074
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,324,930
App. No.
18/612,071
Granted
Jun 10, 2025
Kind
B2
Abstract

Systems and methods for the automatic generation and optimization of radiation therapy treatment plans, and systems and methods for the automatic generation and optimization of an adapted plan in an adaptive radiation therapy workflow.

Claims (33)

1. An automatic treatment planning system, comprising:

a user interface; and

a treatment planning module configured to automatically generate a treatment plan based on objectives derived for clinical goals received via the user interface,

wherein the objectives include dose objectives and helper objectives.

2. The system of claim 1 , wherein the helper objectives are automatically generated.

3. The system of claim 2 , wherein a helper objective is generated for each of the clinical goals that are missing adequate dose information.

4. The system of claim 3 , wherein the treatment planning module comprises:

a quality metric generator generating quality metrics based on the clinical goals;

a dose objective generator configured to automatically generate a helper objective for each of the quality metrics, each helper objective shaping a dose objective of a respective quality metric;

a cost function generator configured to generate a cost function representing the objectives; and

an optimizer configured to generate the treatment plan based on the cost function.

5. The system of claim 4 , wherein the treatment planning module is further configured to evaluate the generated helper objectives for conflict with respective dose objectives.

6. The system of claim 5 , wherein the optimizer is configured to optimize the cost function and determine plan parameters for the treatment plan.

7. A method for automatically selecting helper objectives for a given input of clinical goals, comprising:

generating dose objectives for the clinical goals; and

when the dose objectives do not achieve a desired dose coverage, automatically generate helper objectives to shape the dose objectives of respective clinical goals,

wherein the generating of the helper objectives includes offsetting dose or volume positions of DVH curves generated for the clinical goals.

8. The method of claim 7 , wherein the input clinical goals are prioritized clinical goals.

9. A method for generating helper objectives for a given input of clinical goals, comprising:

determining whether the input clinical goals contain sufficient information to describe a desired dose coverage; and

automatically generating supplementary information to help achieve the desired dose coverage when it is determined that the input clinical goals do not contain sufficient information,

the supplementary information including objectives that help (helper objectives) provide for dose coverage missing from dose objectives derived for the input clinical goals.

10. The method of claim 9 , wherein the automatic generation of the helper objectives includes applying an algorithm to automatically offset dose and/or volume positions of dose-volume histogram (DVH) curves representing dose coverage fulfilling the dose objectives of the input clinical goals.

11. The method of claim 10 , wherein the offsetting of the dose and/or volume positions includes adding or placing additional dose objectives at different dose-volume positions of the dose-volume histogram (DVH) curves to include the missing dose coverage.

12. The method of claim 11 , wherein the helper objectives help shape the dose in a vicinity of a target structure by restricting dose values that are higher than a predetermined amount outside of the target structure.

13. The method of claim 12 , wherein the algorithm is further configured to implement one or more assumptions, including a margin by which the input clinical goals need to be met, and uniformity of dose to the target structure.

14. The method of claim 13 , wherein the helper objectives shape the dose in the vicinity of the target structure based on one or more parameters including one or more of dose prescription, type of the target structure, clinical viability of the desired dose coverage, post-processing disturbance, and dose scaling.

15. The method of claim 14 , wherein the helper objectives include main helper objectives, min/max helper objectives, and additional helper objectives, wherein the main helper objectives are added to the dose-volume axis histogram curves at tighter dose-volume positions for clinical goals having highest priorities, the min/max helper objectives are added at heuristically determined positions, and the additional helper objectives are added at positions that are between the positions of the main helper objectives and the min/max helper objectives.

16. The method of claim 15 , wherein the additional helping objectives are spaced equally in the volume axis of the dose-volume histogram (DVH) curves.

17. The method of claim 16 , wherein the positions of the helper objectives on the dose axis of the dose-volume histogram (DVH) curves can be further offset to account for dose scaling.

18. The method of claim 9 , further comprising generating helper objectives that control the dose values outside of the target structures.

19. The method of claim 9 , further comprising evaluating the helper objectives for conflict between the helper objectives and the dose objectives of the input clinical goals.

20. The method of claim 9 , further comprising generating a treatment plan for a target structure based on the dose objectives and the helper objectives derived for the input clinical goals.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2024
From: PELTOLA, JARKKO; SUHONEN, PAULI; BOYLAN, CHRISTOPHER; THOMPSON, STEPHEN; KUUSELA, ESA
To: VARIAN MEDICAL SYSTEMS INTERNATIONAL AG
Reel/Frame 066863/0737 →
CHANGE OF NAME Recorded Mar 22, 2024
From: VARIAN MEDICAL SYSTEMS INTERNATIONAL AG
To: SIEMENS HEALTHINEERS INTERNATIONAL AG
Reel/Frame 066868/0548 →
Continuity (3)
Division 17665838 · Feb 7, 2022
Division 16564924 · Sep 9, 2019
Related Publication 20240226603A1 · Jul 11, 2024
References Cited (69)
US 7831289B2 · Riker et al. · 2010 [cited by applicant]
US 7986768B2 · Nord et al. · 2011 [cited by applicant]
US 8144833B2 · Breedveld · 2012 [cited by applicant]
US 8363785B2 · Nord et al. · 2013 [cited by applicant]
US 9844684B2 · Luan et al. · 2017 [cited by applicant]
US 10022560B2 · Kumar et al. · 2018 [cited by applicant]
US 10143859B2 · Ollila et al. · 2018 [cited by applicant]
US 10188873B2 · Kuusela et al. · 2019 [cited by applicant]
US 10290093B2 · Albrecht et al. · 2019 [cited by applicant]
US 11278737B2 · Peltola · 2022 [cited by examiner]
US 11612436B2 · McAfee · 2023 [cited by examiner]
US 12011613B2 · Peltola · 2024 [cited by examiner]
US 20170056687A1 · Nord et al. · 2017 [cited by applicant]
US 20170091387A1 · Kuusela et al. · 2017 [cited by applicant]
US 20170340901A1 · Haas et al. · 2017 [cited by applicant]
US 20180185669A1 · Kuusela et al. · 2018 [cited by applicant]
US 20180229056A1 · Paysan et al. · 2018 [cited by applicant]
US 20190012066A1 · Ahonen et al. · 2019 [cited by applicant]
US 20190083813A1 · Ruokokoski et al. · 2019 [cited by applicant]
US 20190172198A1 · Albrecht et al. · 2019 [cited by applicant]
US 20190172210A1 · Albrecht et al. · 2019 [cited by applicant]
US 20190232087A1 · Cordero Marcos et al. · 2019 [cited by applicant]
US 20190247676A1 · Peltola et al. · 2019 [cited by applicant]
US 20190295268A1 · Gass et al. · 2019 [cited by applicant]
US 20190299025A1 · Ruokokoski et al. · 2019 [cited by applicant]
US 20200043580A1 · Kuusela et al. · 2020 [cited by applicant]
US 20200101319A1 · Haas et al. · 2020 [cited by applicant]
US 20200105385A1 · Gass et al. · 2020 [cited by applicant]
US 20200121951A1 · Morgas et al. · 2020 [cited by applicant]
US 20200206532A1 · Kuusela et al. · 2020 [cited by applicant]
US 20200206533A1 · Laaksonen et al. · 2020 [cited by applicant]
CN 108882897A · 2018 [cited by applicant]
CN 109215759A · 2019 [cited by applicant]
CN 109890460A · 2019 [cited by applicant]
CN 110101974A · 2019 [cited by applicant]
CN 110114117A · 2019 [cited by applicant]
CN 110152206A · 2019 [cited by applicant]
CN 110201319A1 · 2019 [cited by applicant]
CN 110310307A · 2019 [cited by applicant]
CN 110314292A · 2019 [cited by applicant]
EP 3229905A1 · 2017 [cited by applicant]
EP 3352851A1 · 2018 [cited by applicant]
EP 3361953A1 · 2018 [cited by applicant]
EP 3424562A1 · 2019 [cited by applicant]
EP 3520859A1 · 2019 [cited by applicant]
EP 3524322A1 · 2019 [cited by applicant]
EP 3546023A1 · 2019 [cited by applicant]
EP 3547257A1 · 2019 [cited by applicant]
EP 3562549A1 · 2019 [cited by applicant]
HK 1259345A · 2019 [cited by applicant]
HK 1262384A · 2020 [cited by applicant]
JP 2019136509A · 2019 [cited by applicant]
KR 101882300B1 · 2018 [cited by applicant]
WO WO2014187866A1 · 2014 [cited by applicant]
WO WO2016144914A1 · 2016 [cited by applicant]
WO WO2019025460A1 · 2019 [cited by applicant]
Office Action issued Dec. 27, 2024, in Chinese Patent Application No. 202080062881.3. [cited by applicant]
Office Action issued Sep. 19, 2024, in European Patent Application No. 20792292.3. [cited by applicant]
Office Action issued May 22, 2024, in Chinese Patent Application No. 202080062881.3. [cited by applicant]
Krayenbuehl et al., “Evaluation of an automated knowledge based treatment planning system for head and neck,” BioMed Central, Radiation Oncology, 2015. [cited by applicant]
Smith et al., “Personalized treatment planning with a model of radiation therapy outcomes for use in multiobjective optimization of IMRT plans for prostate cancer,” BioMed Central, Radiation Oncology, 2016. [cited by applicant]
Barbiere et al., “A parameter optimization algorithm for intensity-modulated radiotherapy prostate treatment planning,” Journal of Applied Clinical Medical Physics, vol. 3, No. 3, Summer 2002. [cited by applicant]
Dumane et al., “Training and evaluation of a knowledge-based model for automated treatment planning of multiple brain metastases,” Journal of Cancer Metastasis and Treatment, 2019. [cited by applicant]
Oliver et al., “Analysis of RapidArc optimization strategies using objective function values and dose-volume histograms,” Journal of Applied Clinical Medical Physics, vol. 11, No. 1, Winter 2010. [cited by applicant]
Kessler et al, “Costlets: A Generalized Approach to Cost Functions for Automated Optimization of IMRT Treatment Plans”, Optimization and Engineering; International Multidisciplinary Journal to Promote Optimizational The… [cited by applicant]
Zarepisheh et al., “A DVH-guided IMRT optimization algorithm for automatic treatment planning and adaptive radiotherapy replanning”, Medical Physics, vol. 41, No. 6, Jun. 1, 2014, pp. 061711. [cited by applicant]
Invitation to Pay Additional Fees and Partial International Search issued Dec. 18, 2020, in PCT Application No. PCT/EP2020/075105. [cited by applicant]
International Search Report and Written Opinion issued Feb. 8, 2021, in PCT Application No. PCT/EP2020/075105. [cited by applicant]
International Preliminary Report on Patentability and Written Opinion issued Mar. 9, 2022, in International Application No. PCT/EP2020/075105. [cited by applicant]